NCT04125056View on ClinicalTrials.gov

Study on Hydronidone Capsule BE

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 16, 2019

Primary Completion Date

January 23, 2019

Study Completion Date

March 4, 2019

Conditions
Healthy
Interventions
DRUG

Hydronidone Capsule(Specification: 30 mg / grain）

Test group

DRUG

Hydronidone Capsule(Specification: 15 mg / grain）

Control group

Trial Locations (1)

430022

Wuhan Union Hospital, Wuhan

All Listed Sponsors
lead

Beijing Continent Pharmaceutical Co, Ltd.

INDUSTRY

NCT04125056 - Study on Hydronidone Capsule BE | Biotech Hunter | Biotech Hunter